norfloxacin has been researched along with gallic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Clos, MV; Di Pietro, O; Espargaró, A; Galdeano, C; Guillou, C; Lamuela-Raventós, RM; Luque, FJ; Muñoz-Torrero, D; Pérez, B; Pérez-Areales, FJ; Ragusa, IM; Sabaté, R; Vallverdú-Queralt, A; Viayna, E | 1 |
| Cirino, IC; de Souza, EL; Diniz-Silva, HT; Falcão-Silva, Vdos S; Magnani, M; Siqueira-Júnior, JP | 1 |
| Campina, FF; Coutinho, HDM; Cunha, FAB; de A Menezes, IR; de Freitas, TS; Dos Santos, JFS; Siqueira-Júnior, JP; Tintino, SR | 1 |
4 other study(ies) available for norfloxacin and gallic acid
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
Topics: Acetylcholinesterase; Aminoquinolines; Amyloid beta-Peptides; Antioxidants; Catechols; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Structure; Protein Aggregates; Protein Aggregation, Pathological; Structure-Activity Relationship; tau Proteins | 2014 |
Tannic Acid as a Potential Modulator of Norfloxacin Resistance in Staphylococcus Aureus Overexpressing norA.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Drug Synergism; Gallic Acid; Gene Expression; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Staphylococcus aureus; Tannins | 2016 |
In vitro e in silico evaluation of the inhibition of Staphylococcus aureus efflux pumps by caffeic and gallic acid.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Caffeic Acids; Drug Resistance, Bacterial; Erythromycin; Ethidium; Gallic Acid; Genes, MDR; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Norfloxacin; Protein Binding; Protein Conformation, alpha-Helical; Protein Interaction Domains and Motifs; Staphylococcus aureus; Thermodynamics | 2018 |